Argenx
ARGX
#544
Rank
S$48.05 B
Marketcap
$787.05
Share price
0.70%
Change (1 day)
56.71%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): S$0.10 Billion

According to Argenx 's latest financial reports the company's current earnings are S$2.19 Billion. , an increase over its 2023 earnings that were of -S$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 S$0.11 B-127.97%
2023 -S$0.4 Billion-58.25%
2022 -S$0.96 Billion
2019 -S$0.27 Billion124.95%
2018 -S$0.12 Billion132.04%
2017 -S$50.04 Million54.86%
2016 -S$32.32 Million33%
2015 -S$24.3 Million13.63%
2014 -S$21.39 Million46.25%
2013 -S$14.62 Million